Purchase Order 75D30124P18389
Award Date 12/7/23
Potential Completion Date 12/6/24
Potential Value $139K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $236,726.60 contract is for a service agreement to provide the CDC with Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software. The contract does not have a set-aside designation and has an ultimate completion date of August 31, 2026....
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,329.00 and a performance period ending on July 20, 2024. The award does not utilize any set-aside provisions. Illumina has a history of providing sequencing systems, reagents, and services to support...
- This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq system, a DNA sequencing instrument, at a ceiling value of $95,931.00. The contract does not have a set-aside designation. Illumina has previously been awarded other prime federal contracts and sub-grants to provide sequencing...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $12,944.40, is for the maintenance of Illumina equipment. It does not have a set-aside designation. Illumina has a history of providing a range of genomic sequencing systems, reagents, and support services to various federal agencies, including the...
- This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for MiSeq and MiniSeq sequencing systems and reagents, with a ceiling value of $132,300.66 and a period of performance through August 31, 2016. This contract does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to federal...